YKL-40: a Potential Biomarker and Therapeutic Target for Breast Cancer Diagnosis and Therapy

References (87)

1. 1 Modes of resistance to anti-angiogenic therapy [DOI]
2. 2 Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures [DOI]
3. 3 Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis [DOI]
4. 4 Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors [DOI]
5. 5 Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. [DOI]
6. 6 Differentiation of the mammary gland and susceptibility to carcinogenesis [DOI]
7. 7 Effect of Variation in CHI3L1 on Serum YKL-40 Level, Risk of Asthma, and Lung Function [DOI]
8. 8 Signaling Pathways in Mammary Gland Development [DOI]
9. 9 Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer.
10. 10 Chitotriosidase, a chitinase, and the 39‐kDa human cartilage glycoprotein, a chitin‐binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages [DOI]
11. 11 The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways [DOI]
12. 12 YKL-40, a secreted glycoprotein, promotes tumor angiogenesis [DOI]
13. 13 Molecular Characterization of the Gene for Human Cartilage gp-39 (CHI3L1), a Member of the Chitinase Protein Family and Marker for Late Stages of Macrophage Differentiation [DOI]
14. 14 Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma [DOI]
15. 15 Gp38k, a Protein Synthesized by Vascular Smooth Muscle Cells, Stimulates Directional Migration of Human Umbilical Vein Endothelial Cells [DOI]
16. 16 YKL-40 (Cartilage gp-39) Induces Proliferative Events in Cultured Chondrocytes and Synoviocytes and Increases Glycosaminoglycan Synthesis in Chondrocytes [DOI]
17. 17 High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer.
18. 18 Human chitinases and chitinase-like proteins as indicators for inflammation and cancer.
19. 19 Clusterin plays an important role in hepatocellular carcinoma metastasis [DOI]
20. 20 Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model [DOI]
21. 21 A Complex of Nuclear Factor I-X3 and STAT3 Regulates Astrocyte and Glioma Migration through the Secreted Glycoprotein YKL-40 [DOI]
22. 22 Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers [DOI]
23. 23 Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C [DOI]
24. 24 Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells [DOI]
25. 25 Identification of proteins secreted by human osteoblastic cells in culture [DOI]
26. 26 Identification of a 38-kDa Heparin-binding Glycoprotein (gp38k) in Differentiating Vascular Smooth Muscle Cells as a Member of a Group of Proteins Associated with Tissue Remodeling [DOI]
27. 27 Isolation and Sequence of a Novel Human Chondrocyte Protein Related to Mammalian Members of the Chitinase Protein Family [DOI]
28. 28 High serum YKL-40 level in patients with small cell lung cancer is related to early death [DOI]
29. 29 Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period [DOI]
30. 30 Identification of low-abundance proteins of bovine colostral and mature milk using two-dimensional electrophoresis followed by microsequencing and mass spectrometry [DOI]
31. 31 Serum Level of YKL-40 is Elevated in Patients with Streptococcus pneumoniae Bacteremia and is Associated with the Outcome of the Disease [DOI]
32. 32 The Chitinase-like Protein YKL-40 Is Secreted by Airway Epithelial Cells at Base Line and in Response to Compressive Mechanical Stress [DOI]
33. 33 Elevated plasma YKL‐40 levels and ischemic stroke in the general population [DOI]
34. 34 Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children [DOI]
35. 35 Inhibitory Activity of YKL-40 in Mammary Epithelial Cell Differentiation and Polarization Induced by Lactogenic Hormones: A Role in Mammary Tissue Involution [DOI]
36. 36 THE INFLAMMATORY BIOMARKER YKL-40 AS A NEW PROGNOSTIC MARKER FOR ALL-CAUSE MORTALITY IN PATIENTS WITH HEART FAILURE [DOI]
37. 37 YKL‐40 and MMP‐9 as serum markers for patients with primary central nervous system lymphoma [DOI]
38. 38 High YKL-40 levels predict mortality in patients with type 2 diabetes [DOI]
39. 39 Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer [DOI]
40. 40 Serum YKL-40: A new potential marker of prognosis and location of métastases of patients with recurrent breast cancer [DOI]
41. 41 Isolation and characterization of a novel 39 kilodaton whey protein from bovine mammary secretions collected during the nonlactating period [DOI]
42. 42 High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival [DOI]
43. 43 The Phylogenetically Conserved Molluscan Chitinase-like Protein 1 (Cg-Clp1), Homologue of Human HC-gp39, Stimulates Proliferation and Regulates Synthesis of Extracellular Matrix Components of Mammalian Chondrocytes [DOI]
44. 44 Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia [DOI]
45. 45 YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer [DOI]
46. 46 YKL-40 Expression in Benign and Malignant Lesions of the Breast: A Methodologic Study [DOI]
47. 47 Increased expression of the inflammatory protein YKL‐40 in precancers of the breast [DOI]
48. 48 YKL ‐40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C [DOI]
49. 49 Gene expression analysis reveals a signature of estrogen receptor activation upon loss ofPtenin a mouse model of endometrial cancer [DOI]
50. 50 No association of (−131C→G) variant of CHI3L1 gene with risk of glioblastoma and prognosis [DOI]
51. 51 Functions of Cell Surface Heparan Sulfate Proteoglycans [DOI]
52. 52 Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis [DOI]
53. 53 Three-dimensional culture models of normal and malignant breast epithelial cells [DOI]
54. 54 Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury [DOI]
55. 55 Rapid vascular regrowth in tumors after reversal of VEGF inhibition [DOI]
56. 56 Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane [DOI]
57. 57 Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis [DOI]
58. 58 In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases [DOI]
59. 59 A new family of growth factors produced by the fat body and active on Drosophila imaginal disc cells [DOI]
60. 60 Crystal Structure and Carbohydrate-binding Properties of the Human Cartilage Glycoprotein-39 [DOI]
61. 61 The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells [DOI]
62. 62 YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma [DOI]
63. 63 Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme [DOI]
64. 64 A YKL-40–Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers [DOI]
65. 65 Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease [DOI]
66. 66 Plasma YKL-40: A Potential New Cancer Biomarker? [DOI]
67. 67 Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: Decreased tumor metastasis in a breast cancer model [DOI]
68. 68 CHI3L1 (YKL‐40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells [DOI]
69. 69 Chitinase 3-Like-1 Expression in Colonic Epithelial Cells as a Potentially Novel Marker for Colitis-Associated Neoplasia [DOI]
70. 70 A public database for gene expression in human cancers.
71. 71 Serum YKL-40 is increased in patients with hepatic fibrosis [DOI]
72. 72 Serum YKL-40 and colorectal cancer [DOI]
73. 73 Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology [DOI]
74. 74 Serum YKL-40, a Potential New Marker of Disease Activity in Patients with Inflammatory Bowel Disease [DOI]
75. 75 Early Detection and Prognosis of Ovarian Cancer Using Serum YKL-40 [DOI]
76. 76 High serum YKL‐40 level after surgery for colorectal carcinoma is related to short survival [DOI]
77. 77 Bevacizumab and Recurrent Malignant Gliomas: A European Perspective [DOI]
78. 78 High Serum YKL-40 Levels in Patients with Primary Breast Cancer is Related to Short Recurrence Free Survival [DOI]
79. 79 Truncation of the β-Catenin Binding Domain of E-cadherin Precedes Epithelial Apoptosis during Prostate and Mammary Involution [DOI]
80. 80 A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection [DOI]
81. 81 High Serum Concentration of YKL-40 Is Associated with Short Survival in Patients with Acute Myeloid Leukemia [DOI]
82. 82 Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects [DOI]
83. 83 Resveratrol represses YKL-40 expression in human glioma U87 cells [DOI]
84. 84 Crystal Structure of a Novel Regulatory 40-kDa Mammary Gland Protein (MGP-40) Secreted during Involution [DOI]
85. 85 Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer [DOI]
86. 86 Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?
87. 87 YKL-40 expression in CD14+liver cells in acute and chronic injury [DOI]

Cited by 4

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Related research

• Use of Bioequivalence Tests and Its Properties under Different Sampling Techniques — shares topic coverage
• Inhibition of Mmp-9 Expression through Nf-Kβ by Natural Compounds as a Possible Therapeutic Adjuvant Strategy in Breast Cancer: A Systematic Review — shares topic coverage
• Effectiveness of Intervention on Awareness and Knowledge of Breast Self-Examination among the Potentially at Risk Population for Breast Cancer — shares topic coverage
• Repurposing Bazedoxifene for Cancer Therapeutics: It is Much more than a SERM — shares topic coverage
• Clinical Significance of Immunoscore in Triple Negative Breast Cancer and Human Epidermal Growth Factor Receptor 2+ Breast Cancer — shares topic coverage